Applications are open for ACCEL, an accelerator for BIPOC-led startups

Ready Year 2

Photo courtesy of Greentown Labs

An accelerator focused on supporting BIPOC-led climatetech startups and addressing inequities in the climatetech industry is accepting applications for its second cohort.

Greentown Labs, the largest climatetech incubator in North America, and Browning the Green Space (BGS), a nonprofit dedicated to making clean energy and other climate-related fields more diverse, equitable, and inclusive, lead the Advancing Climatetech and Clean Energy Leaders Program (ACCEL), which offers access to funding, networking connections, resources, and opportunities that structural inequities put out of reach.

“Opening applications for Year 2 of ACCEL is an important milestone in strengthening critical support for traditionally excluded entrepreneurs in our communities,” says Kerry Bowie, executive director and president of Browning the Green Space.

Benefits for startups accepted into the ACCEL program include:

  • gaining access to extensive mentorship from industry experts
  • $25k in non-dilutive grant funding
  • a curated curriculum of workshops led by experts — including from VentureWell — covering various essential topics for early-stage climatetech founders, such as customer discovery, design-thinking, startup finance, storytelling, and more

“Through our partnership with Greentown and VentureWell, we are able to put our respective strengths together to create an ambitious program to bolster founders of color in climatetech and propel innovations that benefit communities most impacted by climate change,” Bowie says.

For Year 2 of ACCEL, Greentown and BGS are seeking applications from startups at Technology Readiness Levels (TRL) 1-4 that are developing climate solutions for the electricity, transportation, buildings, manufacturing, agriculture, and resiliency and adaptation sectors. Applications are due January 5, 2024.

The Year 2 request for applications comes as a successful inaugural year of ACCEL winds to a close.

ACCEL Year 1 featured six startups working on innovations as diverse as sneakers made from food waste, ultracapacitors built with hemp sourced from Black and Indigenous farmers, and ultra-light solar panels.

Their accomplishments during the accelerator included raising equity funding, earning acceptances into additional accelerators, winning grants, executing customer discovery, and more. Check out more results from Year 1 of ACCEL here.

“ACCEL is one of the most impactful, meaningful programs we’ve run to date,” says Greentown Labs CEO and president Kevin Knobloch. “We are eager to expand upon the great success and momentum of Year 1, and to welcome another incredible cohort of BIPOC-led startups that are developing much-needed climatetech solutions. We’re equally committed to helping these companies accelerate and deploy their solutions, while also helping to build a more diverse, inclusive climatetech workforce — ACCEL sits at the nexus of those two critical efforts.”

Apply for ACCEL Year 2 here and sign up for program updates here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

New TMC partnership aims to grow Houston’s biomanufacturing workforce

workforce partnership

Houston is a frontrunner in the race to introduce and manufacture advanced therapeutics to the medical world. A new agreement between the Texas Medical Center (TMC) and San Jacinto College (SJC) aims to speed more experts and their technologies towards the finish line.

Earlier this month, the world's largest medical center and the nation’s second-ranked community college announced their new partnership that will set students on a path towards careers not only in life sciences in general, but also in pharmaceutical and biomanufacturing specifically.

SJC already has programs in those majors—its first graduates are now joining the workforce—but working with TMC will help the college recruit new students, as well as aid in enrollment and participation. Thanks to this collaboration, SJC students will benefit from more experiential learning and be able to transition more smoothly into the next steps in their training.

“Houston is a premier global hub for life sciences and biotechnology, and the talent we need to advance therapeutic drugs, diagnostics, and cell and gene therapy is already here,” William McKeon, the TMC’s president and CEO, said in a news release. “With more companies choosing to establish their headquarters in Houston and the daily breakthroughs happening across the TMC campus, partnering with San Jacinto College is an important step toward sustaining that momentum and unlocking even greater innovation and growth through the promising talent that already exists within our state.”

The partnership is currently slated to last two years, but the institutions have the option to extend after that.

For students, their journey to becoming scientists will likely start with Biopath @ TMC, a program that introduces high school students to biomanufacturing careers and what it takes to pursue one. Since its inception two years ago, the program has worked with more than 2,000 students around Harris County.

“This partnership exemplifies San Jacinto College’s ability to design and deliver programs that align with current workforce demands while opening doors for untapped talent across the Houston region,” Brenda Hellyer, SJC chancellor, said in the release. “TMC is a key industry leader in our region, and San Jacinto College has a unique global curriculum that provides the foundation and skills required for students to succeed and graduates to thrive in meaningful careers that will contribute to the innovation and advancement of the life sciences.”

Thanks to this new collaboration, more of Houston’s biomanufacturing workforce will soon be locally grown.

Houston legacy planning platform secures $2.5M investment, adds to board

fresh funding

Houston-based Paige, a comprehensive life planning and succession software company, has secured a $2.5 million investment to expand the AI-driven tools on its platform.

The funding comes from Alabama-based 22nd State Banking Company, according to a news release. Paige says it will use the funding to expand automation, AI-driven onboarding and self-service tools, as well as add to its sales and customer success teams.

The company was originally founded by CEO Emily Cisek in 2020 as The Postage and rebranded to Paige last year. It helps users navigate and organize end-of-life planning with features like document storage and organization, password management, and funeral and last wishes planning.

“Too many families are left trying to piece together important information during some of the hardest moments of their lives,” Cisek said in the news release. “This investment allows us to accelerate the next phase of growth for Paige by improving the product and expanding support for our members, our financial institution partners and the communities they serve,”

In addition to the funding news, the company also announced that 22nd State Banking CEO and President Steve Smith will join Paige's board of directors.

“We believe banking should be grounded in relationships and built around the real needs of the people and communities we serve. Paige brings something deeply relevant to that mission," Smith added in the release. "It helps families prepare for the future in a practical and meaningful way, and it gives the banking community new pathways to support customers through important life transitions.”

Paige estimates that $124 trillion in assets will change hands through 2048. Yet about 56 percent of Americans do not have an estate plan.

Read more on the topic from Cisek in a recent op-ed here; or listen to InnovationMap's 2021 interview with her here.

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

View All Listings